You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support
SBC: ASTER LABS, INC. Topic: NIADESCRIPTION (provided by applicant): An estimated 5.4 million Americans had Alzheimer's disease in 2012 and a 50% increase in this number is expected by 2030. The majority of these patients (70%) will live at home where they receive 75% of their care frominformal caregivers, unpaid individuals such as family members, friends, and neighbors. These caregivers provide valuable services, often a ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Advanced Ballistic Shielding for Crew Served Weapons Stations
SBC: Kinetic Protection Topic: N122132The current effort has been on-going, specifically to address the needs as described in N122-132, Advanced Ballistic Shielding for Crew Served Weapons Stations. The objective of the topic is to develop a series of reconfigurable and non-reconfigurable advanced ballistic shields for crew served weapons stations.
SBIR Phase II 2014 Department of DefenseNavy -
A 94 GHz Aperture Coupled Circularly Polarized Transceiver Antenna
SBC: TLC Precision Wafer Technology, Inc. Topic: N/AAdvance millimeter wave (MMW) transceivers are needed to further enhance the U.S. military current and future communication, detection and guidance systems. TLC will develop and demonstrate a unique low-cost, wire-bond-free, 70-94 GHz W-band antennaintegrated MMIC transceiver that also meet commercial performance, low price, and simplicity requirements. This transceiver will also provide excelle ...
SBIR Phase II 2003 Department of DefenseAir Force -
A Low Power Wireless Pulse Oximeter Sensor for Unobtrusive Wearable Applications
SBC: Koronis Biomedical Technologies Corp. Topic: NDESCRIPTION provided by applicant Koronis Biomedical Technology Corporation KBT proposes to develop and evaluate a miniature ultra low power pulse oximeter for long term wearable monitoring There continues to be a clinical need for an unobtrusive pulse oximeter sensor that is small and can be worn comfortably for extended periods of time without battery change or recharge KBT will use eye s ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
A New Chloride Sweat Test for Cystic Fibrosis Screening
SBC: PolyChrome Medical, Inc. Topic: N/ADESCRIPTION (provided by applicant): The CF Quantum(r) sweat test system is a rapid, easily administered, cost effective method to diagnose cystic fibrosis (CF). The CF Quantum(r) patch (Q-patch) uses an ion-exchange reaction to produce a white precipitate which varies in size based on the chloride ion concentration of the sweat sample. Reacting the Q-patch with a chloride-containing solution (i.e ...
STTR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health -
A New Chloride Sweat Test for Cystic Fibrosis Screening
SBC: PolyChrome Medical, Inc. Topic: N/ADESCRIPTION (provided by applicant): The CF Quantum(r) sweat test system is a rapid, easily administered, cost effective method to diagnose cystic fibrosis (CF). The CF Quantum(r) patch (Q-patch) uses an ion-exchange reaction to produce a white precipitate which varies in size based on the chloride ion concentration of the sweat sample. Reacting the Q-patch with a chloride-containing solution (i.e ...
STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
An immunomodulatory yeast-derived beta glucan as a component of a conjugate
SBC: BIOTHERA Topic: NIAIDDESCRIPTION (provided by applicant): Fungal infections, particularly in immunocompromised patients, are a serious and growing problem. Although antifungal therapeutics have improved greatly, failures and relapse are common. Aspergillus fumigatus is a primary cause of these infections in several patient populations: transplants, leukemics, genetic deficiencies such as chronic granulomatous disease ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
An Integrated Publish and Subscribe Architecture Test Harness (InPATH)
SBC: ARCHITECTURE TECHNOLOGY INC Topic: N/AA Publish and Subscribe (P&S) architecture forms the foundation of the Joint Battlespace Infosphere (JBI) system, which is composed of protocols, processes, and common core functions permitting participating applications and organizations to share andexchange mission-critical information in a timely manner. The Air Force is examining various P&S standards that have the potential of forming the bas ...
SBIR Phase II 2003 Department of DefenseAir Force -
A Novel Vaccine to Prevent Urinary Tract Infections
SBC: SYNTIRON, LLC Topic: NIAIDDESCRIPTION provided by applicant Urinary tract infections UTIs caused by extraintestinal pathogenic E coli ExPEC account for nearly million emergency room visits and hospitalizations per year for women in the U S alone Approximately half of all women will experience a symptomatic UTI in their lifetime and will experience a recurrence within to months While several ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Antisense gene therapy with tumor-targeted nanocapsules
SBC: GENESEGUES INC Topic: N/ADESCRIPTION (provided by applicant): Antisense oligonucleotides have generated enormous interest as therapeutic molecules since their initial demonstration in 1978, but their full utilization as effective human therapies has been hampered by inadequate drug delivery to the correct cellular compartment of the correct tissue. We have designed a water-based, ultra-small nanocapsule formulation for ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health